journal article·2025-07-11Open access

Chlorogenic Acid–Strontium-Containing Dual-Functional Bioresorbable External Stent Suppresses Venous Graft Restenosis via Hippo-YAP Signaling Pathway

Ge Zhu, Su Wang, Zhang Liu, Shengji Gu, Feng Chen, Wangfu Zang

Abstract

Vein graft restenosis remains a major complication following coronary artery bypass grafting (CABG), mainly due to the abnormal proliferation of vascular smooth muscle cells (VSMCs) and impaired endothelial repair. While external stents (eStents) can provide mechanical support and limit adverse remodeling, traditional metallic stents are non-degradable and may induce chronic inflammation and fibrosis. In contrast, many bioresorbable materials degrade too quickly or lack mechanical strength. These challenges highlight the need for external stents that combine sufficient mechanical strength with biodegradability to support long-term graft patency. This is the first study that develops a chlorogenic acid–strontium (SrCA)-loaded polycaprolactone bioresorbable eStent that inhibits VSMC proliferation and enhances endothelial repair via Hippo–Yes-associated protein (YAP) signaling, addressing vein graft restenosis post-CABG. Combining mechanical support and biodegradability, it overcomes the limitations of non-degradable stents and rapidly degrading biomaterials, elucidates the potential of natural polyphenol–metal ion complexes in vascular remodeling, and offers an innovative strategy for the prevention of vein graft restenosis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Hippo pathway signaling and YAP/TAZ · Coronary Interventions and Diagnostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cardio-Thoracic Surgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai 200072, China

Shanghai Key Laboratory of Craniomaxillofacial Development and Diseases, Shanghai Stomatological Hospital & School of Stomatology, Fudan University, Shanghai 201102, China

Funding

National Key R&D Program of China · Shanghai Science and Technology Committee

References (53)

Show source-provided references
1. The epidemic of the 20(th) century: Coronary heart disease10.1016/j.amjmed.2014.04.015 ↗
2. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 201310.1016/S0140-6736(14)61682-2 ↗
3. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial10.1016/S0140-6736(13)60141-5 ↗
4. Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk Features10.1161/01.CIR.0000126826.58526.14 ↗
5. Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery10.1056/NEJMoa1716026 ↗
6. Does Previous Transradial Catheterization Preclude Use of the Radial Artery as a Conduit in Coronary Artery Bypass Surgery?10.1161/CIRCULATIONAHA.116.022992 ↗
7. Vein graft failure: From pathophysiology to clinical outcomes10.1038/nrcardio.2016.76 ↗
8. Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery10.1097/SLA.0b013e318288c38d ↗
9. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis10.1038/nrcardio.2015.164 ↗
10. Constrictive external nitinol meshes inhibit vein graft intimal hyperplasia in nonhuman primates10.1016/j.jtcvs.2008.02.068 ↗
11. A novel biodegradable external mesh stent improved long-term patency of vein grafts by inhibiting intimal–medial hyperplasia in an experimental canine model10.1007/s11748-015-0591-2 ↗
12. A novel Nanocellulose-Gelatin-AS-IV external stent resists EndMT by activating autophagy to prevent restenosis of grafts
13. Expandable external support device to improve Saphenous Vein Graft Patency after CABG10.1186/1749-8090-8-122 ↗
14. A randomized trial of an external Dacron sheath for the prevention of vein graft disease: The Extent study10.1016/j.jtcvs.2007.01.092 ↗
15. Vascular Graft Infections10.1016/j.idc.2018.06.003 ↗
16. A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting10.1016/j.athoracsur.2015.01.060 ↗
17. External stenting and disease progression in saphenous vein grafts two years after coronary artery bypass grafting: A multicenter randomized trial10.1016/j.jtcvs.2021.03.120 ↗
18. Multivascular networks and functional intravascular topologies within biocompatible hydrogels10.1126/science.aav9750 ↗
19. 3D bioprinting of collagen to rebuild components of the human heart10.1126/science.aav9051 ↗
20. The role of Hippo/yes-associated protein signalling in vascular remodelling associated with cardiovascular disease10.1111/bph.13806 ↗
21. Ruiter, M.S., and Pesce, M. (2018). Mechanotransduction in Coronary Vein Graft Disease. Front. Cardiovasc. Med., 5.10.3389/fcvm.2018.00020 ↗
22. Yap1 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin10.1074/jbc.M111.329268 ↗
23. Structure elucidation and inhibitory effects on human platelet aggregation of chlorogenic acid from Wrightia tinctoria10.1515/jcim-2012-0048 ↗
24. Chlorogenic acid prevents isoproterenol-induced hypertrophy in neonatal rat myocytes10.1016/j.toxlet.2014.02.016 ↗
25. Chlorogenic acid a dietary polyphenol attenuates isoproterenol induced myocardial oxidative stress in rat myocardium: An in vivo study10.1016/j.biopha.2016.09.028 ↗
26. A chlorogenic acid-phospholipid complex ameliorates post-myocardial infarction inflammatory response mediated by mitochondrial reactive oxygen species in SAMP8 mice10.1016/j.phrs.2018.01.006 ↗
27. Chlorogenic acid ameliorates isoproterenol-induced myocardial injury in rats by stabilizing mitochondrial and lysosomal enzymes10.1016/j.biopha.2016.11.067 ↗
28. Application of strontium-doped calcium polyphosphate scaffold on angiogenesis for bone tissue engineering10.1007/s10856-013-4891-8 ↗
29. Strontium ions protect hearts against myocardial ischemia/reperfusion injury10.1126/sciadv.abe0726 ↗
30. Elastic 3D-Printed Hybrid Polymeric Scaffold Improves Cardiac Remodeling after Myocardial Infarction10.1002/adhm.201900065 ↗
31. (1996). Guide for the Care and Use of Laboratory Animals. Standard No. No. 85-23.
32. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease10.1016/j.jtcvs.2014.11.002 ↗
33. Review: In CAD, CABG reduced 5-year mortality more than PCI in multivessel but not left main disease10.7326/ACPJC-2018-168-12-066 ↗
34. The Choice of Conduits in Coronary Artery Bypass Surgery10.1016/j.jacc.2015.08.395 ↗
35. Role of smooth muscle cells in coronary artery bypass grafting failure10.1093/cvr/cvy021 ↗
36. Biomedical application and controlled drug release of electrospun fibrous materials10.1016/j.msec.2018.05.007 ↗
37. Recent advances in 3D-printed polylactide and polycaprolactone-based biomaterials for tissue engineering applications10.1016/j.ijbiomac.2022.07.140 ↗
38. The in vivo degradation, absorption and excretion of PCL-based implant10.1016/j.biomaterials.2005.09.019 ↗
39. Yang, Q., Lei, D., Huang, S., Yang, Y., Jiang, C., Shi, H., Chen, W., Zhao, Q., You, Z., and Ye, X. (2020). A novel biodegradable external stent regulates vein graft remodeling via the Hippo-YAP and mTOR signaling pathways. Biomaterials, 258.10.1016/j.biomaterials.2020.120254 ↗
40. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients with Coronary Stent Restenosis10.1016/j.jacc.2020.04.006 ↗
41. Chlorogenic acid prevents isoproterenol-induced DNA damage in vascular smooth muscle cells10.3892/mmr.2016.5743 ↗
42. Chen, Y., Ye, M., Wang, X., Li, W., and Chen, W. (2022). Functionalized gelatin/strontium hydrogel bearing endothelial progenitor cells for accelerating angiogenesis in wound tissue regeneration. Biomater. Adv., 136.10.1016/j.bioadv.2022.212803 ↗
43. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors10.1038/nm.1941 ↗
44. A chlorogenic acid functional strategy of anti-inflammation, anti-coagulation and promoted endothelial proliferation for bioprosthetic artificial heart valves10.1039/D2TB02407A ↗
45. Chlorogenic acid releasing microspheres enhanced electrospun conduits to promote peripheral nerve regeneration10.1039/D3BM00920C ↗
46. In Vitro Degradation and In Vivo Biocompatibility of Strontium-Doped Magnesium Phosphate-Reinforced Magnesium Composites10.1021/acsbiomaterials.2c00142 ↗
47. Sahoo, S., Sinha, A., and Das, M. (2020). Synthesis, characterization and in vitro biocompatibility study of strontium titanate ceramic: A potential biomaterial. J. Mech. Behav. Biomed. Mater., 102.10.1016/j.jmbbm.2019.103494 ↗
48. Bioinspired NO release coating enhances endothelial cells and inhibits smooth muscle cells10.1039/D1TB01828K ↗
49. Toll Receptor-Mediated Hippo Signaling Controls Innate Immunity in Drosophila10.1016/j.cell.2015.12.029 ↗
50. Cytoskeletal tension inhibits Hippo signaling through an Ajuba-Warts complex10.1016/j.cell.2014.05.035 ↗
51. Mechanisms of Hippo pathway regulation10.1101/gad.274027.115 ↗
52. The induction of yes-associated protein expression after arterial injury is crucial for smooth muscle phenotypic modulation and neointima formation10.1161/ATVBAHA.112.254730 ↗
53. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP10.1016/j.yjmcc.2015.11.024 ↗